Insight

Felipe Roitberg: A powerful Tool for decision-making process support.

Photo from Felipe Roitberg/LinkedIn

Sep 17, 2023, 16:42

Felipe Roitberg: A powerful Tool for decision-making process support.

Quoting Felipe Roitberg, Technical Officer (Cancer-NCD) at the World Health Organization, Ukraine, on LinkedIn:

“Just out our publication!
World Health Organization (WHO) Essential Medicines List applications and decisions reviewed in the context of ESMO-Magnitude of Clinical Benefit Scale (MCBS)- value-based scale.

A powerful tool for decision-making process support: pre-selection of cancer medicines.
Real cases to illustrate it
— Affordability is still a major barrier for adoption.”

For the article, click here.
Source: Felipe Roitberg/LinkedIn.

cancer Dario Trapani Felipe Roitberg George Pentheroudakis Giuseppe Curigliano Magnitude of Clinical Benefit Scale Martina Galotti Nicola Latino OncoDaily Oncology Word Health Organization

Senator Edward Markey in Response to OncoDaily About Pediatric Cancer Funding

In Memory of Alan Rickman and His Battle with Prostate and Pancreatic Cancer

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC

Oncologist Near Me – Nazik Hammad: A Leader in Cancer Care, Medical Education, and Health Equity